Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues

Abstract

Organic anion transporters (OATs) translocate drugs as well as endogenous substances and toxins. The prototype, OAT1 (SLC22A6), first identified as NKT in 1996, is the best-studied member of the OAT subgroup of the SLC22 transporter family, which also includes OCTs (organic cation transporters), OCTNs (organic cation transporters of carnitine) and Flipts (fly-like putative transporters). The SLC22 family is evolutionarily conserved, with members expressed in fly and worm. An unusual feature of many SLC22A genes is a tendency to exist in pairs or clusters in the genome. Much of the early research in the field focused on the role of OATs and other SLC22 family members in renal drug transport. OATs have now been localized to other epithelial tissues, including placenta (OAT4) and mouse olfactory mucosa (Oat6). Although findings from in vivo physiological studies in mice lacking OATs (e.g. Oat1 and Oat3) have generally been consistent with in vitro transport data from Xenopus oocytes and transfected cells, these in vivo data are helping to clarify the relative contributions of individual OATs to the renal excretion of particular organic anions and drugs. Moreover, in mutant mice, certain endogenous anions accumulate, suggesting the physiological roles of the proteins encoded by the mutant genes. It has been proposed that the presence of OATs and other SLC22-family members in multiple tissue compartments might enable a 'remote sensing' mechanism by allowing communication between organs, and possibly individuals, through organic ions. Variability of human drug responses and susceptibility to drug toxicity might, in part, be explained by variations in the coding and promoter regions of these genes. Computational biological studies are likely to not only shed light on molecular mechanisms of transport for compounds of clinical and toxicological interest, but also aid in drug design.

Key Points

  • Organic anion transporters (OATs) translocate drugs (e.g. antibiotics, diuretics, nonsteroidal anti-inflammatory agents, antiviral agents), endogenous substances (e.g. folate) and nephrotoxins (e.g. ochratoxin A and mercurials)

  • Seven OATs—all members of the SLC22 family—have been identified

  • OATs are antiporters, linked to the sodium–dicarboxylate cotransporter and the sodium–potassium ATPase

  • OAT1 and OAT3 are expressed in the basolateral membranes of tubule cells

  • Study of OAT single nucleotide polymorphisms might facilitate prediction of drug response and toxicity in individual patients

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. You G (2002) Structure, function, and regulation of renal organic anion transporters. Med Res Rev 22: 602–616

    Article  CAS  Google Scholar 

  2. Sweet DH et al. (2001) The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol Renal Physiol 281: F197–F205

    Article  CAS  Google Scholar 

  3. Wright SH and Dantzler WH (2004) Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84: 987–1049

    Article  CAS  Google Scholar 

  4. Eraly SA et al. (2004) The molecular pharmacology of organic anion transporters: from DNA to FDA? Mol Pharmacol 65: 479–487

    Article  CAS  Google Scholar 

  5. Moller JV and Sheikh MI (1982) Renal organic anion transport system: pharmacological, physiological, and biochemical aspects. Pharmacol Rev 34: 315–358

    CAS  PubMed  Google Scholar 

  6. Miyazaki H et al. (2004) The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci 25: 654–662

    Article  CAS  Google Scholar 

  7. Lopez-Nieto CE et al. (online 29 March 1997) Mus musculus kidney-specific transport protein mRNA, complete cds. GenBank accession number: U52842 [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=1293671] (accessed 11 June 2007)

  8. Lopez-Nieto CE et al. (1996) Molecular cloning and characterization of a novel transport protein with very high expression in the kidney [abstract]. J Am Soc Nephrol 7: a1301

    Google Scholar 

  9. Lopez-Nieto CE et al. (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272: 6471–6478

    Article  CAS  Google Scholar 

  10. Pavlova A et al. (1999) Evolution of gene expression patterns in a model of branching morphogenesis. Am J Physiol Renal Physiol 277: F650–F663

    Article  CAS  Google Scholar 

  11. Sekine T et al. (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272: 18526–18529

    Article  CAS  Google Scholar 

  12. Sweet DH et al. (1997) Expression cloning and characterization of ROAT1: the basolateral organic anion transporter in rat kidney. J Biol Chem 272: 30088–30095

    Article  CAS  Google Scholar 

  13. Wolff NA et al. (1997) Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett 417: 287–291

    Article  CAS  Google Scholar 

  14. Grundemann D et al. (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372: 549–552

    Article  CAS  Google Scholar 

  15. Eraly SA and Nigam SK (2002) Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters. Biochem Biophys Res Commun 297: 1159–1166

    Article  CAS  Google Scholar 

  16. Eraly SA et al. (2004) Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiol Genomics 18: 12–24

    Article  CAS  Google Scholar 

  17. Van Aubel RAMH et al. (2000) Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 279: F216–F232

    Article  CAS  Google Scholar 

  18. Dresser MJ et al. (2001) Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 90: 397–421

    Article  CAS  Google Scholar 

  19. Sweet DH (2005) Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol Appl Pharmacol 204: 198–215

    Article  CAS  Google Scholar 

  20. Brady KP et al. (1999) A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics 56: 254–261

    Article  CAS  Google Scholar 

  21. Burckhardt BC and Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95–158

    Article  CAS  Google Scholar 

  22. Schnabolk GW et al. (2006) Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). Am J Physiol Renal Physiol 291: F314–F321

    Article  CAS  Google Scholar 

  23. Hong M et al. (2005) Human organic anion transporter hOAT1 forms homooligomers. J Biol Chem 280: 32285–32290

    Article  CAS  Google Scholar 

  24. Tanaka K et al. (2004) Role of glycosylation in the organic anion transporter OAT1. J Biol Chem 279: 14961–14966

    Article  CAS  Google Scholar 

  25. You G et al. (2000) Regulation of mOAT-mediated organic anion transport by okadaic acid and protein kinase C in LLC-PK1 cells. J Biol Chem 275: 10278–10284

    Article  CAS  Google Scholar 

  26. Bow DA et al. (2006) The impact of plasma protein binding on the renal transport of organic anions. J Pharmacol Exp Ther 316: 349–355

    Article  CAS  Google Scholar 

  27. Brater DC et al. (1983) Bumetanide and furosemide. Clin Pharmacol Ther 34: 207–213

    Article  CAS  Google Scholar 

  28. Kim GH (2004) Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol 24: 595–605

    Article  CAS  Google Scholar 

  29. Eraly SA et al. (2006) Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem 281: 5072–5083

    Article  CAS  Google Scholar 

  30. Sweet DH et al. (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 [Slc22a8]) knockout mice. J Biol Chem 277: 26934–26943

    Article  CAS  Google Scholar 

  31. Eraly SA et al. (2003) Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun 300: 333–342

    Article  CAS  Google Scholar 

  32. Groves CE et al. (1998) Peritubular transport of ochratoxin A in rabbit renal proximal tubules. J Pharmacol Exp Ther 284: 943–948

    CAS  PubMed  Google Scholar 

  33. Aslamkhan AG et al. (2003) Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol Pharmacol 63: 590–596

    Article  CAS  Google Scholar 

  34. Bahn A et al. (2002) Interaction of the metal chelator 2,3-dimercapto-1-propanesulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1). Mol Pharmacol 62: 1128–1136

    Article  CAS  Google Scholar 

  35. Zalups RK and Barfuss DW (2002) Renal organic anion transport system: a mechanism for the basolateral uptake of mercury-thiol conjugates along the pars recta of the proximal tubule. Toxicol Applied Pharmacol 182: 234–243

    Article  CAS  Google Scholar 

  36. Ho ES et al. (2000) Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11: 383–393

    CAS  PubMed  Google Scholar 

  37. Shitara Y et al. (2005) Evaluation of drug–drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 45: 689–723

    Article  CAS  Google Scholar 

  38. Nozaki Y et al. (2004) Quantitative evaluation of the drug–drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier. J Pharmacol Exp Ther 309: 226–234

    Article  CAS  Google Scholar 

  39. Buist SC et al. (2003) Endocrine regulation of rat organic anion transporters. Drug Metab Dispos 31: 559–564

    Article  CAS  Google Scholar 

  40. Buist SCN and Klaassen CD (2004) Rat and mouse differences in gender-predominant expression of organic anion transporter (oat1-3; slc22a6-8) mRNA levels. Drug Metab Dispos 32: 620–625

    Article  CAS  Google Scholar 

  41. Ljubojevic M et al. (2004) Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 287: F124–F138

    Article  CAS  Google Scholar 

  42. Cerrutti JA et al. (2002) Sex differences in p-aminohippuric acid transport in rat kidney: role of membrane fluidity and expression of OAT1. Mol Cell Biochem 233: 175–179

    Article  CAS  Google Scholar 

  43. Xu G et al. (2005) Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int 68: 1491–1499

    Article  CAS  Google Scholar 

  44. Bleasby K et al. (2005) Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther 314: 923–931

    Article  CAS  Google Scholar 

  45. Fujita T et al. (2005) Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics 15: 201–209

    Article  CAS  Google Scholar 

  46. Bhatnagar V et al. (2006) Analyses of 5′ regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J Hum Genet 51: 575–580

    Article  CAS  Google Scholar 

  47. Pavlova A et al. (2000) Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol 278: F635–F643

    Article  CAS  Google Scholar 

  48. Sweet DH et al. (2006) Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int 69: 837–845

    Article  CAS  Google Scholar 

  49. Nakajima N et al. (2000) Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney. Kidney Int 57: 1608–1616

    Article  CAS  Google Scholar 

  50. Sekine T et al. (2006) Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290: F251–F261

    Article  CAS  Google Scholar 

  51. Kaler G et al. (2006) Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions. Biochem Biophys Res Commun 351: 872–876

    Article  CAS  Google Scholar 

  52. Monte JC et al. (2004) Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 323: 429–436

    Article  CAS  Google Scholar 

  53. Schnabolk GW et al. (2006) Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). Am J Physiol Renal Physiol 291: F314–F321

    Article  CAS  Google Scholar 

  54. Kusuhara H and Sugiyama Y (2005) Active efflux across the blood–brain barrier: role of the solute carrier family. NeuroRx 2: 73–85

    Article  Google Scholar 

  55. Cha SH et al. (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275: 4507–4512

    Article  CAS  Google Scholar 

  56. Nagata Y et al. (2002) Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol 61: 982–988

    Article  CAS  Google Scholar 

  57. Sekine T et al. (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429: 179–182

    Article  CAS  Google Scholar 

  58. Simonson G et al. (1994) Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 107: 1065–1072

    CAS  PubMed  Google Scholar 

  59. Eraly SA et al. (2003) Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens 12: 551–558

    Article  CAS  Google Scholar 

  60. Kaler G et al. (2007) Structural variation governs substrate specificity for organic anion transporters (oat) homologs: potential remote sensing by oat family members. J Biol Chem [doi:10.1074/jbc.M703467200]

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjay K Nigam.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nigam, S., Bush, K. & Bhatnagar, V. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Rev Nephrol 3, 443–448 (2007). https://doi.org/10.1038/ncpneph0558

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0558

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing